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disease states [3-6] and orthostatic dysfunction [7,8]. These
redistributions affect cardiovascular function, water balance
and perhaps skeletal muscle function through physiological
mechanisms that may be better understood with simultaneous characterization of both the extent and rate of the intercompartment redistributions that take place during fluid
management therapy.
Objective methods to monitor such factors include tracer
dilution techniques, which are invasive, time consuming, and
expensive, and cannot be repeated in the short intervals
that are required to follow events over the usual time course
of interest. Bioelectric impedance instrumentation may be
used to monitor these changes in the body and may be a
valuable aid in clinical diagnosis and research.
Two different types of bioelectric impedance instruments
are available. Fixed frequency bioelectrical impedance
plethysmographic (IPG) techniques are valuable noninvasive
tools that provide information about overall segmental
volumes, blood flows, and hemodynamic status with a high
degree of temporal resolution [9-12]. The second type,
electrical bioimpedance spectroscopy (BIS) [13,14] is a multifrequency technique that, when coupled with computeraided equivalent circuit analysis, may be used to provide
information about relative redistributions of fluids between
the intra-and extracellular compartments of the monitored
segments.

Abstract
This paper describes a new combined impedance plethysmographic
(IPG) and electrical bioimpedance spectroscopic (BIS) instrument
and software that allows noninvasive real-time measurement of
segmental blood flow and changes in intracellular, interstitial, and
intravascular volumes during various fluid management
procedures. The impedance device can be operated either as a
fixed frequency IPG for the quantification of segmental blood flow
and hemodynamics or as a multi-frequency BIS for the recording of
intracellular and extracellular resistances at 40 discrete input
frequencies. The extracellular volume is then deconvoluted to
obtain its intra-vascular and interstitial component volumes as
functions of elapsed time. The purpose of this paper is to describe
this instrumentation and to demonstrate the information that can
be obtained by using it to monitor segmental compartment
volumes and circulatory responses of end stage renal disease
patients during acute hemodialysis. Such information may prove
valuable in the diagnosis and management of rapid changes in the
body fluid balance and various clinical treatments.
Keywords: Bioimpedance, plethysmograph, spectroscopy,
compartment volumes, blood flow

Introduction
Hemodynamic redistribution of fluids between body
segments and between the intracellular and extracellular
compartments within those segments are often of central
importance to various fluid management procedures [1,2],
This work is licensed under a Creative Commons Attribution 3.0 Unported License
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the intensive care unit, and of highly premature infants. It
can also be used to investigate chronic fatigue syndrome and
other disease states that involve autonomic impairment of
the cardiovascular system.

Tissues are ionic conductors of electric current, which by
virtue of their structural heterogeneity, exhibit dielectric
relaxation phenomena that give rise to frequency dependent
variations of the impedance to such conduction [15]. In the 1
- 150 kHz range, the resultant dielectric dispersions arise
principally from the capacitive reactances of cell membranes. At low frequencies in this range, high cell membrane
reactances prohibit current flux through cells, so that tissular
impedance is governed by properties of the extracellular
fluid. At high frequencies, membrane reactance is negligible,
allowing current to pass through both the extra- and
intracellular spaces. Tissular impedance is then governed by
the combined properties of the two compartments. Time
series of tissue impedances measured as a function of
frequency consequently embody tissue structural information that can illuminate changes in the relative distributions
of fluids between the tissular intra- and extracellular compartments [16-19].
Various resistance/capacitance (R/C) models [15,16,
20,21] are used to quantify segmental volumes from
recorded impedance measurements. The R/C model that is
used by most currently available impedance systems (Figure
1) represents the tissue as two parallel conductance paths;
one through an extracellular compartment having average
resistance (Re), and the other through an intracellular
compartment having average resistance (Ri ) and capacitance (Cm). This model, which is limited to the determination
of “intracellular” and “extracellular” resistances (Ri and Re,
respectively), can therefore only be used to estimate the
corresponding intracellular, extracellular, and overall
monitored segment volumes.

Background
A major component of our analytical procedure is the
development and application of a more complex equivalent
circuit model [22-24], illustrated in Figure 2A, which can be
used to calculate the interstitial and intravascular compartment volumes that comprise the previously calculated
“extracellular” volume.
The extravascular soft tissue compartment of the
monitored segment is then represented in our model as a
cylindrical homogeneous suspension of identical oblate
spheroidal cells with long axes, a, oriented parallel to the
applied field, I, as shown in Figure 2B. Cells are allowed to
change volume only through variation in minor axis, b. The
cell volume fraction and the intracellular and extracellular
conductivities of this compartment are related to the
compartment’s Re, Ri, and Cm in Figure 1 with theory
developed by Hugo Fricke [25-29].
Ri

Cm

Re
Rblood
Rbone

Figure 2A: Equivalent Circuit Diagram used in EIS Analysis for
Intracellular, Interstitial, and Intravascular Volumes.

I
Figure 1: General equivalent circuit model of current
conduction through tissue.

Unfortunately, an issue of principal concern in most
clinical contexts is how the “extracellular volume” is
distributed between its interstitial and intravascular
compartments; an issue that the two component R/C
models cannot address. We have developed a more complex
model to remedy this deficiency.
This study will describe a new analytical procedure that
uses BIS data to obtain quantitative values of intracellular,
interstitial, and intravascular volume changes and relative
transfer of fluids between these compartments of a given
body segment. Potential applications of this capability in the
clinical environment include monitoring of the hydration
status of patients during surgery, during dialysis, or while in

a

b

Figure 2B: Extra-vascular soft tissue compartment of EIS model.

Our model is based on an assumed physical structure of
the monitored segment; particularly its extravascular
compartment (Figure 2A); which governs the values and
frequency dependence of the “resistive” and “reactive”
components of the segmental impedance. The model is fit to
each measured spectrum by an iterative numerical process
in which values of the model parameters are found that
bring model-prescribed spectra into closest possible
agreement with the measured spectrum.
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4) The software includes the current level and
resistance/reactance values at each frequency. The
software also includes an added Pulsatile Module that
saves time segments of Pulsatile data as separate ASCII
files. The software allows recording BIS, IPG, or a
scheduled (software settable) combination of the two.
The PC Software is designed and tested to operate
under Windows 2000 and Windows XP operating
systems, and support unit operation via either RS232 or
USB interfaces under each of these operating systems.
5) The system includes internal signal conditioning and A-D
conversion capability for ECG and photoelectric pulse
(from UFI 1020) channels. ECG and photoelectric
channels have variable size controls located on the front
panel.
6) Instrument calibration factors are stored within the
instrument to enable the use of generic support/
interface software on all similar BIS units.

Because the model is a function of more parameters
than are uniquely determined by information in an
impedance spectrum, selected model parameters must be
assigned “fixed” values in the fitting process.
Materials and methods
Device description
The Z-Spec-2, (UFI Inc., Morro Bay, CA) combines two
bioimpedance instruments into a single device. It combines a
fixed frequency impedance plethysmograph (IPG) and a
multi-frequency electrical bioimpedance spectrograph into
one unit. The IPG mode is used to quantify segmental blood
flow and total segmental conductive volume. The BIS mode
is used to monitor segmental intracellular and extracellular
compartment volumes as is done by other BIS devices.
However, our proprietary software also allows the Z-Spec-2
to divide the extracellular compartment volume into its
intravascular and interstitial components.
The current Z-Spec-2 design, shown in Figure 3, is a
unique bioimpedance measurement device that supplies
subject tissue impedance while "sweeping" across 40
discrete excitation frequencies over a wide frequency range
when functioning as a BIS for compartment volume
measurements. The Z-Spec-2 can be paused at 50 kHz to
function as a fixed frequency IPG for blood flow
measurements.
The Z-Spec-2 provides a “scheduler” capability that can
be used to operate the instrument continuously as either an
IPG or an BIS or any desired time sequenced combination of
the two modes.
The Z-Spec-2 includes a Lead I electrocardiographic (ECG)
and a photoelectric plethysmographic (PPG) analog channel
(via external transducers) which provide measures that are
used to quantify segmental blood flow.
A built-in 16 bit microcontroller is responsible for
management of all Z-Spec-2 functions.
Figure 4 shows the basic functional block diagram of our
Z-Spec-2 EIS/IPG instrumentation.

Application
The application and capability of the BIS when operated in
the IPG mode to quantify segmental blood flow and
hemodynamics is described elsewhere (4,6). Details of the
analytical algorithm used to derive individual fluid compartment volumes from the impedance spectroscopic recordings
are given in previous articles [30-32].
We hypothesize that this new instrument will be able to
quantify changes in the three fluid compartments as fluid
volume is removed during hemodialysis. We therefore,
aimed to evaluate the changes in the three volume
compartments (intravascular, interstitial, and intracellular),
and hemodynamic patterns associated with fluid volume
removal during dialysis.
Equipment validation
Hemodialysis treatment sessions provide ideal opportunities
to monitor exogenously induced inter-compartmental fluid
shifts with minimal additional procedures. If the BIS net
volume changes we compute do indeed provide a way to
track three compartment fluid shifts, then such BIS-recorded
fluid shifts should correlate with those of an independent
physiologic measure of fluid volume changes.
The hemodialysis (HD) patient’s hematocrit (HCT),
expressed as %, rises (due to hemoconcentration) as excess
fluids are removed by ultra-filtration (UF) – and falls or rises
more slowly (due to hemodilution) as extravascular fluid
moves into the vascular system as a result of compensatory
osmotic and hydrodynamic pressure changes. Both changes
in HCT and changes in the rate of vascular “refill” can be
measured noninvasively during routine HD therapy sessions.
Changes in HCT can be measured by a CritLine® optical
monitor (HemaMetrics, Kaysville, UT). The rate of “refill”
can be calculated from the BIS volume data.

Z-Spec-2 design features
The Z-Spec-2 final design has the following features:
1) Combines both BIS (Z-Spec-2) and IPG (Fixed Frequency)
capability in a single device using the current BIS
enclosure. Includes the current BIS Function and
Circuitry. A "Pulsatile Size" switch is included on front
panel for the IPG function.
2) Operates from an isolated power supply with either an
in-line or wall-mount transformer for power from a
120V 60Hz AC power source (with no battery power).
3) Front panel includes an LCD display that shows real-time
plots of ECG, photoelectric pulse signals (switch
selectable) and Delta-Ro signals.

42

Montgomery et al.: A system to monitor segmental changes during hemodialysis. J Electr Bioimp, 8, 40-53, 2017

Figure 3: Prototype Z-Spec-2 IPG/EIS system (shown with control/data recording laptop and Arc Simulator unit).

Figure 4: Z-Spec-2 functional block diagram.

from the BIS data during hemodialysis, to mathematically
derive post hoc hematocrit profiles. These profiles were
then compared to the simultaneously measured hematocrit
values recorded independently using the CritLine® monitor.
Regression and Bland Altman analyses were used to
compare the BIS data and CritLine® hematocrits at sequential
times during the 60 chronic HD sessions with the patients in
a horizontal position. The statistical and graphical evidence
obtained [31] confirmed that the BIS system reliably
monitors the continuous and real time rates of change of the
fluid volumes of the three compartments in the chronic
treatment setting.

A CritLine® optical monitor served as the “gold standard”
for validation and was used simultaneously to detect on-line
changes in hematocrit. The CritLine® measures the optical
absorption and scattering properties of red blood cells as
they pass through the HD circuit. Since red blood cell mass
and hemoglobin do not usually change during treatment, the
relative changes in hematocrit should parallel the changes in
blood fluid content. The CritLine® instrument is well
validated [33,34], FDA-approved [35,36], and routinely used
for patient management.
Validation was previously performed in 60 End Stage
Renal Disease patients during chronic treatment session by
analyzing the time profiles of fluid redistribution, obtained
43
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However, it has been shown that the fluid responses in
the intracellular, interstitial and intravascular compartments
may differ during the acute and chronic HD sessions [37].
It was therefore necessary to replicate the earlier
validation procedures using the bioimpedance data from the
22 end stage kidney disease (ESKD) patients that took part in
this study.

dialysis. Compartment volume results were displayed in real
time, while blood flow and hemodynamic properties were
computed in post-session analyses. Changes in interstitial
and intravascular volumes from the BIS recordings were
used to calculate the HCT-time profile for each patient..

Statistics
Statistical analysis was performed using MedCalc Ver.
10.0.0.0. A Student’s t test was used to compare paired
observations. Pearson’s correlation (38) and Bland-Altman
(39) analyses were used to compare the BIS hematocrit
(BISHCT) and the CritLine® hematocrit (CLHCT) results at
each time point. Results are reported as mean ± SD.

Source
Sampling

Validation of BIS used during acute HD treatment
The institutional review board approved protocol allowed
BIS measurement in consented adult ESKD patients receiving
dialysis in an acute dialysis unit. Patients with the following
conditions were excluded from the study: irregular
heartbeat, unstable angina, active gastrointestinal bleeding,
pregnancy, poor peripheral circulation, skin conditions such
as psoriasis, damaged nerves in the arms or legs, liver
failure, cancer, collagen vascular disease such as lupus,
chronic swelling of the arms or legs due to obstruction of the
lymph or blood vessels, implanted pacemaker, or other
implanted electrical device, overactive thyroid disease, or
chronic substance abuse. Studies were performed in
patients who were resting in the supine position for at least
2 hours before obtaining measurements.
All patients were treated with Cobe Century hemodialysis machine and Polyflux 170H dialyzer. Dialysis fluid
sodium concentration (140 mEq/L) and ultrafiltration rate
(UFR) were kept constant throughout the treatment. Blood
flow rate, dialysis fluid flow rate, treatment time, and total
volume removed were ordered by the Attending physician
according to the patient’s requirement.
Blood Pressure (BP) and heart rate (HR) were measured
and recorded by a technician immediately before dialysis,
every 15 minutes throughout the treatment, and at the end
of treatment. Signs and symptoms related to hypotension
and dialysis complications were recorded. All patients were
treated in the supine position.
Hematocrit (HCT), an indirect measure of blood volume
(BV), was continuously monitored on-line using CritLine®TQA (Hema-Metrics, Kaysville, UT). Percent change in BV
(%BV) during HD was determined from the % variation of
HCT.
A bioelectric impedance spectroscopic system (LDM, San
Jose, CA and UFI, Inc., Morro Bay, CA) was used to obtain
periodic, noninvasive relative measurements of intracellular
(Vc), interstitial (Vi), and intravascular (Vb) volumes,
segmental blood flow and hemodynamic properties during

Sampling

Source

Figure 5: Electrode placement.

The BIS instrument was attached to the subject’s
dominant lower leg. The source electrodes were placed just
above the knee, and just above the malleolus, laterally. The
sampling electrodes were placed just below the knee and
above the ankle, medially. Figure 5 shows electrode
placement on the calf.
All dialysis sessions included in this analysis lasted at
least 120 minutes. Shortly after 120 minutes some of the
dialysis sessions were terminated for different reasons;
patients experiencing syncope, cramps, completion of the
required dialysis, etc. Mean calculated BIS and observed
CritLine® hematocrit (± SD) values are presented in Table 1
for elapsed dialysis times of 30, 60, 90, 120, and END. The
END values that are given in Table 1 were taken from the
last minute before cessation of dialysis. The average ( ± SD)
time for the END data is 171.2 ± 21.7 min. from the start of
dialysis. The CritLine® hematocrit values measured by the
optical sensor in Table 1 and the following tables and figures
are designated CLHCT. The values calculated from the BIS
measurements are designated by BISHCT. No significant
differences were found between the BISHCT and the CLHCT
values at any of the elapsed times listed in Table 1.
Results of the regression and Bland Altman analyses, at
each of the elapsed times, are listed in Table 1. Graphical
results of the regression and Bland Altman analyses at the
specified elapsed times are given in Figures 6A and 6B,
respectively.
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Table 1. BIS and CritLine Hematocrit values ± SD at specified elapsed times during dialysis.
ELAPSED TIME
N
BISHCT
BISHCT SD
CLHCT
CLHCT SD
(min)
(%)
(%)
30
22
31.91
4.68
31.91
4.68
60
22
32.14
4.73
32.12
4.71
90
22
32.36
4.73
32.32
4.67
120
22
32.52
4.71
32.59
4.68
End
22
33.06
4.96
33.09
4.96

The regression equation and R2 value for BISHCT vs.
CLHCT are given in Figure 6A. The solid trace in Figure 6A
represents the corresponding regression equation. The
BISHCT/CLHCT points included in the Bland Altman analysis
for each time period are represented as: 30 min. are open

circles, 60 min. are solid squares, 90 min. are solid circles,
120 min. are open triangles, and the END values are open
squares.
Table 2 lists the corresponding Bland Altman results.

Table 2. Differences ± SD, limits of agreement, and independent t-test probabilities of significance between
BISHCT and CLHCT values at specified elapsed times during dialysis.
ELAPSED TIME
Difference with CLHCT
Limits of agreement
P
(min)
(mean ± 1.96SD)
(by non-pair t-test)
30
-0.00692 ± 0.0318
-0.0692 ± 0.0799
0.996
60
-0.01166 ± 0.1393
-0.2847 ± 0.3686
0.993
90
- 0.03235 ± 0.2469
-0.5163 ± 0.6415
0.982
120
0.06657 ± 0.2492
-0.4218 ± 0.7467
0.962
END
0.03746 ± 0.1590
-0.2742 ± 0.4715
0.980

2.0
1.5

CLHCT - BISHCT

1.0
0.5

+1.96 SD
0.35
Mean
-0.01
-1.96 SD
-0.37

0.0
-0.5
-1.0
-1.5
-2.0
20

Figure 6A: Linear regression and Bland Altman analyses comparing the
BISHCT and CLHCT results at specified times during dialysis.

25

30
35
Average of CLHCT and BISHCT

40

45

Figure 6B: Bland Altman analysis. The BISHCT/CLHCT points included
above for each time period are represented as: 30 min. are open
circles, 60 min. are solid squares, 90 min. are solid circles, 120 min. are
open triangles, and the END values are open squares.

These regression and Bland Altman analyses confirm that
the BIS algorithm can be used to reliably derive the continuous and real time rates of change of the intra-cellular,
interstitial, and intravascular compartmental fluid volumes
in both acute and chronic ESKD patients.
Regression results yielded a R2 > 0.99 between the two
measures of hematocrit at different times during dialysis.
The slopes of the regression equations at the different times
were nearly identical, demonstrating an almost one to one
correspondence between the calculated BIS and the
measured CritLine® hematocrits.

Bland Altman analyses show that the BIS algorithm can
be used interchangeably with the CritLine® monitor for the
measurement of hematocrit. In addition, it also shows that
the calculated volume changes can then be used to derive
other variables that can provide valuable insight into the
various fluid responses that take place during fluid
management therapy.
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or in those patients being treated during their initial fluid
management therapy.
To demonstrate the capability of the ZSpec-2 to provide
information regarding fluid compartment volume and
circulatory changes for individual patients during HD we
provide the results of two very different patients below. The
results of BIS and CritLine® along with simultaneous BP and
hemodynamic (blood flow) measurements were obtained in
the two ESKD patients:

Dialysis Demonstration
The intracellular, interstitial and intravascular volume
changes that were calculated from the series of HD sessions
used in the above validation study are given in Figures 7A, B
and C, respectively below. Figure 7 shows that the three
component volumes of the acute patients undergoing HD
varied widely among the individual patients. This finding
may, in part, be attributed to the differences in the progression of ESKD and other accompanying diseases of the various
patients. The patients monitored during these acute HD
sessions were in the hospital for treatment of a number of
disease states and/or complications of their kidneys. As
such, they may have been given HD for the first time in our
facility without knowledge as to their responses during
previous HD treatments.

1) Patient Type A, a 57-yr old male with long-standing
hypertension and past medical history of congestive
heart failure and
2) Patient Type B, a 26 year old male with long-standing
type-1 diabetes mellitus complicated by severe diabetic
autonomic neuropathy, diabetic retinopathy, and
diabetic nephropathy.

300

Volume - ML

200

Prior to dialysis, both patients had no overt signs of
congestive heart failure or fluid overload and showed
comparable pre-dialysis BP. As shown in Figures 8A and 8B
the ultrafiltration (UF) rates were similar, e.g. 1.0-1.3 L/hr
and the total amount of fluid removed during dialysis was
the same for both patients.

100
0
0

50

100

150

200

-100
-200
Elapsed Time - Min.

Figure 7A: Individual patient intracellular volume changes during
dialysis vs elapsed time.
UF - L/HR, Amt. Rev. - L
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200
100

Volume - ML

0
-100 0

50

100
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200

-200
-300
-400
-500

3.5
A-UF rate (L/hr)

3.0

A-Amt. Rmoved (L)

2.5
2.0
1.5
1.0
0.5
0.0

-600
-700

0

50

-800

100

150

200

Elapsed time - Min.
Elapsed Time - Min.

Figure 8A: Patient Type A's - UF rate and amount removed vs. elapsed
time.

Figure 7B: Individual patient interstitial volume changes
during dialysis vs elapsed time.

4.0

UF - L/HR, Amt. Rev. - L

100

Volume - ML

50
0
0

50

100

150

200

-50
-100
-150

3.5
B-UF rate (L/hr)

3.0

B-Amt. Removed (L)

2.5
2.0
1.5
1.0
0.5
0.0
0

Elapsed Time - Min.

50

100

150

200

Elapsed time - Min.

Figure 7C: Individual patient intravascular volume changes
during dialysis vs elapsed time.

Figure 8B: Patient Type B's - UF Rate an Amount Removed vs.
elapsed time.

Due to the observed variance of the individual patients,
each patient had to be considered as a specific case for HD
treatment. Use of the BIS system, described herein, would
greatly facilitate administration of HD in the acute patients

Figures 9A and 9B illustrate the change in the CritLine®
HCT and the corresponding HCT calculated from the BIS data
for the Type A and B patients, respectively. The HCT for the
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Type A patient increased from 24% to approximately 27%
during dialysis. That of Type B increased from ~37.5% to
39%. The extent of agreement between the CritLine®
measured HCT and that of the calculated values for both
patients show that the algorithms used to derive the three
fluid compartment volumes may be used for both chronic
and acute patients during dialysis.

Volume change - ML

600

27.5

400
200
0
-200

0

50

-400

A-Total

-600

A-Vi

100

150

200

A-Vc
A-Vb

-800

Elapsed Time - Min.

27.0
26.5

A Prediction

Figure 10A: Patient Type A's segmental and compartment volume
changes vs. elapsed time.

26.0
25.5
25.0

20

24.5

10

Volume change - ML

Hematocrit - %

A HCT

24.0
0

50

100

150

200

Elapsed time - Min.

Figure 9A: Measured and predicted HCT values for Patient Type A
vs. elapsed time.
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-20
-30
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-50

B-Total
B-Vc
B-Vi
B-Vb

-60

Elapsed time - Min.

40
39

B HCT

Hematocrit - %

38

Figure 10B: Patient Type B's total segmental and compartment
volume changes vs. elapsed time.

B Prediction

37
36
35

Subject A’s BP remained stable throughout the entire HD
session with practically the same UF rate of about 1 L/hr.
Hence, there was no intradialytic hypotension (IDH)
However, the decline in vascular volume during HD was
temporally accompanied by a proportionate decrease in
interstitial volume. This suggests that a proportionate
amount of vascular refilling occurred, which may have
prevented the development of IDH (Figure 10A).
Figure 10B shows that Patient B had a progressive
decline in vascular volume, which reached its climax toward
the end (130-180 min) of the HD session, while both
interstitial and cellular volumes remained relatively stable. In
Patient B an IDH episode was noted near the end of dialysis
session when the same UF rate of about 1 L/hr was applied.
This hypotensive response is consistent with his impaired
autonomic function.
The individual compartment volumes are then used to
provide a measure of outflow or “refill” from the extravascular (XV) space into the vascular system during dialysis.
In patient Type A, XV fluid moved to refill the intravascular
space, Figure 11A. Whereas in patient Type B, not much fluid
was transferred from the XV space into the vascular system
resulting in hypotension and symptoms of dizziness, Figure
11B.

34
33
32
31
30
0

50

100

150

200

Elapsed time - Min.

Figure 9B: Measured and predicted HCT values for Patient Type B
vs. elapsed time.

Results
Compartment volume changes calculated from multifrequency recordings
Figures 10A and 10B depict the volume changes of the
intracellular, interstitial and intravascular fluid compartments of the Type A & B patients, respectively. HD in the
Type A patient with minimal BV change was accompanied by
removal of a large volume of fluid from the interstitial space
and an increase in cellular volume. HD in the Type B patient
with marked decrease in BV was accompanied by minimal
net changes in both the interstitial and cellular volumes.
The fluid removed from the Type A patient appears to be
primarily from the extravascular (Vb and Vi) space. Whereas,
fluid removed from the Type B patient was mainly from the
vascular space, leading to symptoms of low blood pressure
and dizziness.
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The systolic blood pressure of the Type B patient
dropped about 55 mmHg during the total dialysis
treatment, which included a 45 mmHg during the last
hour of dialysis. Note that the large decrease in Type
B's systolic blood pressure started at approximately
125 min elapsed time. This time was the period in
dialysis at which the maximum amount of fluid was
removed from the intravascular compartment (Figure
11B).
Figure 12B shows that the diastolic BP of the two
patients experience decrease at the same points in elapsed
time. Type B's diastolic blood pressure decreased approximately 30 mmHg and that of Type A decreased ~10 mmHg.

Volume change - ML

0
-50 0

50

100

150

200

-100
-150
-200
-250
-300
A-XV

-350

A-Vb

-400
-450

Elapsed time - Min.

Figure 11A: Patient Type A's intravascular and extravascular
volume changes vs. elapsed time.
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-40
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90
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B-Diastolic BP

70

A-Diastolic BP

60
0

50

-50

Elapsed time - Min.

150

200

Figure 12B: Patient Type A and B's diastolic blood pressure vs.
elapsed time.

Figure 11B: Patient Type B's intravascular and extravascular
volume changes vs. elapsed time.

Figure 12C illustrates the mean arterial pressure =
diastolic + 1/3(pulse pressure) that results from the blood
pressure responses displayed above. MAP decreased from
~ 125 mmHg to ~85 mmHg for Type B and remained
relatively constant for Type A, decreasing approximately 10
mmHg during the last period of dialysis.

Blood pressure - mmHg

Segmental blood pressures, blood flow, and vascular state
calculated from hand recorded blood pressures and fixed
frequency impedance data
The following results were obtained from the hand recorded
blood pressures and the output of the bioimpedance
instrument when it was operated in its fixed frequency
mode with a constant input current of 50 kHz and the
pulsatile waveforms recorded for a period of 60 seconds.
The parameter values provided below were calculated using
the Rheosys computer program [16] and are mainly
dependent upon the morphology and shape of the recorded
pulsatile waveforms.
Blood pressure
Figure 12A shows that the systolic BP of the Type A patient
remains relatively stable, dropping about 15 mmHg during
dialysis.
Blood pressure - m m Hg

100

Elapsed time - Min.

130
120
110
100

B-MAP
A-MAP

90
80
0

50

100

150

200

Elapsed time - Min.

Figure 12C: Patient Type A and B's mean arterial blood pressure
vs. elapsed time.
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Segmental Blood Flow
The following results compare the changes in heart rate
(Figure 13A), maximum pulse amplitude (Figure 13B) and
resulting calf blood flow (Figure 13C) for Patients A and B
during dialysis.
One potential contributing factor to Patient B's
responses may be the observation that the various physiologic mechanisms that normally respond to minimize
hypotension are inactive or become fatigued during dialysis
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Figure 12A: Patient A and B's systolic blood pressure vs. elapsed
time.
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increased dramatically twice during the Type B patient
dialysis.
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Figure 13B: Patient Type A and B’s maximum blood pulse
amplitude vs. elapsed time.
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of ESKD patients who exhibit serious complications or
advanced kidney disease. Also, the various parameters that
are displayed tend to become less effective after
approximately 125 - 150 minutes elapsed time during which
the compartment volumes experienced their maximum fluid
removal.
These results were obtained even though both patients
had the same relative UF rate and similar amounts of total
fluid withdrawn. The Type B patient had several conditions
that may have altered or influenced his
autonomic/sympathetic responses to dialysis. The Type A
patient did not have (at the time of study) any complications
that might alter his natural responses to dialysis.
Heart rate (BPM - Figure 13A) was calculated from time
between subsequent QRS peaks of the recorded ECG
waveforms. The heart rate of both patients increased during
dialysis. Patient A's heart rate increase from approximately
75 BPM to 90 BPM during dialysis while that of patient B
only increased about 5 BPM.
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Figure 13C: Patient Type A and B’s calf blood flow vs. elapsed
time.
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Figure 13A: Patient Type A and B's heart rate vs. elapsed time.

The maximum pulse amplitude (Amp) for each patient
(Figure 13B) was taken from the maximum height of the
systolic portion of the bioimpedance waveform when
converted to ohms resistance. Amp increased for the Type A
patient and decreased slightly for the Type B patient.
The heart rate and pulse amplitude responses above
yield an increase in calf blood flow (ml/100ml/min) for Type
A and a decrease of ~ 50% for Type B between 25 and 100
min of dialysis as shown in Figure 13C.
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Figure 14A: Patient Type A and B’s pulse transit time vs. elapsed
time.
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Pulse Transit Time and Peripheral Resistance
Pulse Transit Time (PTT - sec, Figure 14A) is the time interval
between the ECG QRS complex and the start of the
bioimpedance pulse waveform. PTT remains constant for
Type A and increases markedly for Type B starting about 125
min elapsed time. This PTT increase indicates that the
systemic circulation of the Type B patient dilated extensively
starting at approximately 125 min elapsed time.
Peripheral resistance (PR, Figure 14B) is defined as
MAP/%BF (where BF is in units of ML/100 ML/Min). PR
remained constant during the Type A patient dialysis but
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Figure 14B: Patient Type A and B’s peripheral resistance vs. elapsed time.
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2.0

Arteriolar tone - %

In the Type A patient, PR remained relatively stable in
association with no changes in BP. In the Type B patient,
however, PR increased initially and became erratic
subsequently but did not increase in association with the fall
in BP near the end of dialysis session.
Contractility and Balance of Arterial and Venous Tone
The average blood pulse inflow angle (LA - between 10 and
90% of pulse amplitude) (Figure 15) is a measure of the
contractility of the heart. An increase in LA indicates an
increase in the contractility of the heart. LA of the Type A
patient increases slightly during most of the dialysis period.
LA is more varied for the Type B patient and decreases at
150 min showing a reduction in contractility at that point in
time.
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Figure 16A: Patient Type A and B’s arteriolar tone vs. elapsed time.
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Figure 16B: Patient Type A and Bs venular tone vs. elapsed time.
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The intravascular compartment was able to refill its fluid
volume with that from the interstitial compartment. On the
other hand, pattern type B represents a symptomatic
hemodialysis treatment in which the patient experienced
low blood pressure, tachycardia, cramps, and lightheadedness. In this situation, the intravascular compartment was
unable to refill with fluid volume and the patient became
hypotensive.
BIS also showed an increase in intracellular volume (Vc)
while fluid was removed from the Type A patient. We
speculated that the fluid originated from the extracellular
compartments (Vi and Vb) (Figure 10A). The Type B patient
was not able to tolerate fluid removal. The intracellular and
interstitial fluid volume did not change significantly. Total
body fluid removal originated from the intravascular
compartment (Vb) (Figure 10B).
The BIS system reliably monitors the continuous and real
time rates of change of the fluid volumes of the three
compartments. The BIS intravascular volume changes
correlate with the simultaneously measured changes in
hematocrit (as the index of blood volume change).
During dialysis, progressive removal of fluid with UF in
Patient A was associated with no change in systemic arterial
pressure but a marked increase in arteriolar tone. By
contrast, a similar rate of fluid removal resulted in a marked
fall in arterial pressure with no change in arteriolar tone in
Patient B. This lack of an increase in arteriolar tone during
fluid removal may be related to impaired arteriolar
constriction due to decreased sympathetic nervous activity,
commonly found in diabetic patients with autonomic
neuropathy.

Elapsed time - Min.

Figure 15: Patient Type A and B’s average blood pulse inflow
angle vs. elapsed time.

Arteriolar tone is expressed as the Dicrotic Index (DCI Figure 16A) and is defined as the ratio of the maximum
amplitude of the post-dicrotic segment of the impedance
pulse waveform to the maximum amplitude of the pulse
(17). Venular tone is given as the Diastolic Index ( DSI Figure 16B) and is defined as the pulse amplitude at the
time of the dicrotic notch to the maximum amplitude of the
pulse (18). DCI and DSI indicate the response of the local
vascular bed in the calf segment during dialysis.
Figure 16A shows that there is a marked increase in
arteriolar tone for Patient B while that of Patient A remains
constant during dialysis.
The venular tone responses of the two patients (Figure
16B) are similar to the arteriolar tone responses; venular
tone remained constant for patient A and increased for
Patient B.
Discussion
The BIS system demonstrates the relative volume in each
fluid volume compartment, namely, intracellular (Vc),
interstitial (Vi), and intravascular (Vb). Moreover, we
demonstrated fluid movement during hemodialysis in which
there was net fluid removed from the human body. We
observed two distinct patterns that patients experience.
Pattern type A represents a hemodialysis treatment in
which the patient did not suffer any hypotensive symptoms.
50

Montgomery et al.: A system to monitor segmental changes during hemodialysis. J Electr Bioimp, 8, 40-53, 2017

measure these changes during HD plays a central role to
prescribing volume removal and control that will improve
tolerance and avoid hypotension and other symptoms
associated with hypotension. They also indicate that the
system described above may find useful application in other
clinical or research investigations.
Limitations of the study include:
1) We have used conventional R/C components in our
revised equivalent circuit analysis model. This was done
to ensure that our current representation would be
completely compatible with our previous BIS analytical
procedures. As explained in the Background section of
this article, we use an ancillary cell model in our work
that allows for cellular expansion and contraction.
Inclusion of a ‘constant phase element’ in future
equivalent circuit models may improve results from
studies of this type.
2) A presumption that the intercompartmental fluid shifts
in the limb during HD reflect total body fluid shifts.
3) Validation with the Critline.

There are several important physiological considerations
regarding fluid volume changes during HD. The changes in
intravascular volume during HD are primarily a function of
the rate of fluid removal or ultrafiltration (UF) and the
patient's vascular refilling of fluid from the extravascular
space. During HD, the fluid removed by UF comes directly
from the intravascular compartment. This fluid derives from
both the intravascular and the interstitial compartments
and, in some cases, from the intracellular fluid space. This
implies a continuous refilling of fluid from the extravascular
to the vascular compartment as a compensatory mechanism
to minimize huge reductions in circulating blood volume,
which if left unchecked leads to “overt hypovolemia”. This, in
turn, often results in low blood pressure during dialysis or
“intradialytic hypotension”, the most common complication
of dialysis that is associated with increased morbidity and
mortality. The plasma refilling rate can be simply calculated
as the difference between the total fluid loss and plasma
volume loss per unit time.
The most frequent complication of HD is hypotension as
exemplified in Patient B in the present study. In this patient,
intradialytic hypotension developed near the end of an HD
session, as fluid is being removed at a steady rate by UF
(vide supra). Of particular interest pertains to the simultaneously measured BIS showing a progressive decline in
vascular volume, which reached its climax toward the end
(130-180 min) of HD session, while both interstitial and
intracellular volumes remained relatively stable. These
findings can be explained as follows. During HD, continuous
removal of fluid from the vascular compartment results in
progressive decline in plasma volume perhaps because of
insufficient or impaired vascular refilling. As a consequence,
the interstitial volume changes little and the progressive
decline in plasma volume in the absence of vascular refilling
will ultimately result in intradialytic hypotension due to
impaired vasoconstriction from autonomic dysfunction.
By contrast, Patient A did not develop intradialytic
hypotension and blood pressures remained relatively stable
throughout the entire HD session with the same UF rate of
about 1L/ hour as in patient B. However, the measured BIS
showed that the initial decline in vascular volume during HD
was temporally accompanied by a proportionate decrease in
interstitial volume with only a small decrease in blood
pressure. In this case, it is possible a proportionate amount
of vascular refilling occurred despite the same rate of UF
removal, which may have preserved circulating blood
volume and hence prevented the development of intradialytic hypotension.
These findings have several important therapeutic
implications. During HD, circulating blood volume, a key
determinant of blood pressure, may variably change as a
result of ultrafiltration depending upon fluid volume shifts
between intravascular and extravascular (interstitial and
intracellular) compartments. The ability to accurately

This study demonstrates for the first time that the BIS
method can reliably provide real-time continuous
measurements of compartmental intravascular, interstitial,
and intracellular fluid volume and cardiovascular changes
that occur during HD treatment. Such information may
prove valuable in the diagnosis and management of rapid
changes in body fluid balance. Furthermore, BIS measurements can be used to predict who will have a symptomatic
hemodialysis treatment with hypotension. As a result, the
dialysis treatment could be adjusted accordingly so patient
will not have hypotensive symptoms.
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